Domov › Ulcerativni kolitis › Florida
Klinične študije za Ulcerativni kolitis v Florida
31 študij za Ulcerativni kolitis išče udeležence na lokacijah v Florida.
Mesta v Florida
- Orlando22 študij
- Miami21 študij
- Tampa9 študij
- Sarasota6 študij
- Kendall5 študij
- Jacksonville4 študij
- Coral Springs3 študij
- St. Petersburg3 študij
- Spring Hill3 študij
- Pensacola3 študij
Uradno besedilo študije (angleško)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Synergy Healthcare - Bradenton - 17th Avenue West /ID# 284157, Bradenton
- Clinical Research of Osceola /ID# 280593, Kissimmee
- Florida Center For Gastroenterology - Largo /ID# 281059, Largo
- in še 3
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Access Research Institute, Brooksville
- Gastro Florida, Clearwater
- Digestive and Liver Center of Florida, P.A., Kissimmee
- in še 5
Vključevanje udeležencevFaza 4
Starost 18–80 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT06581328A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- Nicklaus Children's Hospital - Miami - Southwest 62nd Avenue /ID# 271585, Miami
Vključevanje udeležencevFaza 3
Starost 2–17 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07071519Confirmatory Clinical Study in Active Ulcerative Colitis
- ARA Professionals, Miami
- Orlando Gastroenterology, P.A., Orlando
- Tropical Clinical Trials, Palmetto Bay
Vključevanje udeležencevFaza 2
Starost 16 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07296315A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Novum Research, LLC, Clermont
- I.V.A.M. Clinical & Investigational Center, LLC, Doral
- Florida Research Institute, Lakewood Rch
- in še 9
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT06598943Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Bradenton
- Xencor Investigative Site, Brandon
- Xencor Investigative Site, Jacksonville
- in še 5
Vključevanje udeležencevFaza 1/2Vabljeni zdravi prostovoljci
Starost 18–75 · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT06619990A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 007, Kissimmee
- 029, Miami
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-026, Orlando
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT07845487A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
- Nature Coast Clinical Research ( Site 1045), Inverness
- Research Associates of South Florida - Miami - Southwest 8th Street ( Site 1072), Miami
- AdventHealth Orlando ( Site 1074), Orlando
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07463183A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- Clinical Research of Osceola, LLC, Kissimmee
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT06979336A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- American Institute of Research, Cutler Bay
- Nature Coast Clinical Research, Inverness
- Florida Research Institute, Lakewood Rch
- in še 1
Vključevanje udeležencevFaza 3
Starost 12 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07196748Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Research Associates of South Florida - Miami - Southwest 8th Street, Miami
- Gastro Health Research - Miami, Miami
- Orlando Health, Orlando
- in še 3
Vključevanje udeležencevFaza 3
Starost 18–70 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06937086LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- NeoClinical Research, Hialeah
- Encore Borland-Groover Clinical Research, Jacksonville
- Clinical Research of Osceola, Kissimmee
- in še 4
Vključevanje udeležencevFaza 2
Starost 18–80 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07186101A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Gastro Health Research - Miami, Miami
- Ezy Medical Research, Miami Lakes
Vključevanje udeležencevFaza 2
Starost 18–80 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07483073LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- K2 Medical Research - Daytona Beach, Daytona Beach
- Clinical Research of Osceola, Kissimmee
- Florida Research Institute, Lakewood Rch
- in še 1
Vključevanje udeležencevFaza 2
Starost 18–80 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- Endoscopic Research Inc, Orlando
- Alliance Clinical Research of Tampa, LLC, Tampa
Vključevanje udeležencevFaza 4
Starost 18–65 · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT06095128Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
- Miami Clinical Research, Miami
- GCP Clinical Research, Tampa
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT07513181A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Royal Palm Clinical Research - Site Number: 8400065, Fort Myers
- Clinical Research of Osceola - Site Number: 8400013, Kissimmee
- Bioresearch Partner-Kendale Lakes - Site Number: 8400053, Miami
- in še 1
Vključevanje udeležencevFaza 3
Starost 16–80 · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT07185009A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ONO-6414 Administered Orally in Healthy Adult Participants and Patients With Active Ulcerative Colitis
- Syneos Health Miami, Miami
Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci
Starost 18–55 · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07749768A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Florida Research Center Inc., Lakewood Rch
- Sanchez Clinical Research, Inc, Miami
- GCP Clinical Research, Tampa
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 28. avg. 2026 · NCT07577856A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
- Primary Care of Osceola, Kissimmee
- Florida Research Institute, Lakewood Rch
- University of Miami, Miami
- in še 1
Vključevanje udeležencevFaza 2
Starost 18–80 · Vsi spoli · Posodobljeno 21. avg. 2026 · NCT06636656An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Novum Research, LLC - Site Number: 8400003, Clermont
- Precision Clinical Research-Site Number: 8400059, Coral Springs
- Sarkis Clinical Trials-Ocala - Site Number: 8400048, Gainesville
- in še 12
Vključevanje udeležencevFaza 3
Starost 16–80 · Vsi spoli · Posodobljeno 20. avg. 2026 · NCT07184996Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- Mayo Clinic Jacksonville, Jacksonville
- Advent Health, Orlando
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT05230173Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- University of Miami, Miami
- AdventHealth, Orlando
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 5. avg. 2026 · NCT07237516An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- Digestive and Liver Center of Florida Kissimmee, Kissimmee
- Orlando Health/Digestive Health Institute, Orlando
Vključevanje udeležencevOpazovalna študija
Starost 18–64 · Vsi spoli · Posodobljeno 9. jul. 2026 · NCT06398626A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- Arnold Palmer Hospital - Center for Digestive Health and Nutrition, Orlando
Vključevanje udeležencevFaza 2
Starost 12–17 · Vsi spoli · Posodobljeno 8. jul. 2026 · NCT05287126R-3750 in Patients With Mild to Moderate Ulcerative Colitis
- AP Medical Research LLC, Miami
- Edward Jenner Research Group, LLC, Plantation
- Adtremed Research Clinic, Tampa
Vključevanje udeležencevFaza 1
Starost 18–65 · Vsi spoli · Posodobljeno 12. jun. 2026 · NCT05666960ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool
- Med-Care Research Corp, Miami
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 22 in več · Vsi spoli · Posodobljeno 28. apr. 2026 · NCT06810518Tailored Anti-Inflammatory (A-I) Diet for Americans With Ulcerative Colitis (UC)
- University of Miami Health System, Miami
Vključevanje udeležencev
Starost 16–75 · Vsi spoli · Posodobljeno 30. mar. 2026 · NCT06784323A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Miami
- Mirador Therapeutics Selected Site, Miami
- Mirador Therapeutics Selected Site, Miami
- in še 3
Vključevanje udeležencevFaza 2
Starost 18–80 · Vsi spoli · Posodobljeno 12. mar. 2026 · NCT07113522Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
- University of Miami Health, Miami
- Orlando Health, Orlando
Vključevanje udeležencev
Starost 18–85 · Vsi spoli · Posodobljeno 8. jan. 2026 · NCT05987852Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.